Loading clinical trials...
Loading clinical trials...
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Conditions
Interventions
LY3556050
Placebo
Locations
40
United States
Simon Williamson Clinic
Birmingham, Alabama, United States
Synexus- Chandler
Chandler, Arizona, United States
Synexus Clinical Research - Glendale
Glendale, Arizona, United States
Alliance for Multispecialty Research - Clinical Research Consortium
Tempe, Arizona, United States
Irvine Clinical Research
Irvine, California, United States
Artemis Institute for Clinical Research
Riverside, California, United States
Start Date
November 12, 2020
Primary Completion Date
October 21, 2021
Completion Date
October 21, 2021
Last Updated
November 2, 2023
NCT07153471
NCT07351968
NCT06381791
NCT06747494
NCT07327931
NCT06906939
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions